The National Pharmaceutical Pricing Authority (NPPA) fixed the prices 39 drugs that are added to the price control list, which covers over 500 drugs.

The latest move of the government will include medicines made by pharmaceutical companies, including Cadila Healthcare, Lupin, IPCA Laboratories, Abbott Laboratories and GlaxoSmithKline.
The new drugs join a price control list that covers more than 500 drugs. In the month of May, NPPA had capped the prices of 30 formulation packs, including the drugs that treat tuberculosis, diabetes and asthma.
The move comes after a parliamentary committee said in April that the scope of price control needed to be expended.
Source-Medindia
MEDINDIA




Email





